Partha Sardar

Summary

Publications

  1. doi request reprint Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials
    Partha Sardar
    Division of Cardiovascular Medicine, University of Utah Health Science Center, University of Utah, 30 North 1900 East, Salt Lake City, UT 84132, USA
    Eur Heart J 36:2373-80. 2015
  2. doi request reprint Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials
    Partha Sardar
    Department of Cardiology, Texas Tech University Health Sciences Center, El Paso, Texas, USA Electronic address
    Can J Cardiol 30:888-97. 2014
  3. doi request reprint Health resource variability in the achievement of optimal performance and clinical outcome in ischemic heart disease
    Partha Sardar
    Department of Medicine, New York Medical College, Valhalla, NY, USA
    Curr Cardiol Rep 17:1. 2015
  4. doi request reprint Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials
    Partha Sardar
    Texas Tech University Health Sciences Center, El Paso, TX, United States Electronic address
    Int J Cardiol 179:279-87. 2015
  5. doi request reprint Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials
    Partha Sardar
    Department of Medicine, New York Medical College Metropolitan Hospital Center, 1901 First Avenue, New York, NY, USA
    J Thromb Thrombolysis 38:1-10. 2014
  6. doi request reprint Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation
    Partha Sardar
    Department of Medicine, New York Medical College, New York, New York Electronic address
    Am J Cardiol 113:1173-7. 2014
  7. doi request reprint Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials
    Partha Sardar
    Department of Medicine, New York Medical College Metropolitan Hospital Center, 1901 First Avenue, New York, NY, USA
    Drugs 73:1171-82. 2013
  8. doi request reprint Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis
    Saurav Chatterjee
    Division of Cardiology, St Luke s Roosevelt Hospital Center of the Mount Sinai Health System, New York, New York
    JAMA 311:2414-21. 2014
  9. doi request reprint New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials
    Partha Sardar
    Department of Medicine, New York Medical College Metropolitan Hospital Center, New York, New York
    J Am Geriatr Soc 62:857-64. 2014
  10. doi request reprint New oral anticoagulants in patients with cancer: current state of evidence
    Partha Sardar
    1Department of Medicine, New York Medical College, New York, NY 2Department of Cardiology, St Luke s Roosevelt Hospital of the Mount Sinai Health System, New York, NY 3Department of Medicine, New York Medical College Metropolitan Hospital Center, New York, NY and 4Department of Medicine, Cardiology Division, New York Medical College, Valhalla, NY
    Am J Ther 22:460-8. 2015

Detail Information

Publications19

  1. doi request reprint Endovascular therapy for acute ischaemic stroke: a systematic review and meta-analysis of randomized trials
    Partha Sardar
    Division of Cardiovascular Medicine, University of Utah Health Science Center, University of Utah, 30 North 1900 East, Salt Lake City, UT 84132, USA
    Eur Heart J 36:2373-80. 2015
    ..The purpose of this meta-analysis was to systematically examine clinical outcomes in RCTs comparing the use of intravenous (IV) fibrinolysis alone to IV fibrinolysis plus EVT, for the treatment of acute ischaemic stroke...
  2. doi request reprint Novel oral anticoagulants in patients with renal insufficiency: a meta-analysis of randomized trials
    Partha Sardar
    Department of Cardiology, Texas Tech University Health Sciences Center, El Paso, Texas, USA Electronic address
    Can J Cardiol 30:888-97. 2014
    ..A meta-analysis was performed to evaluate the efficacy and safety with recommended doses of NOAC compared with conventional treatment in patients with renal insufficiency...
  3. doi request reprint Health resource variability in the achievement of optimal performance and clinical outcome in ischemic heart disease
    Partha Sardar
    Department of Medicine, New York Medical College, Valhalla, NY, USA
    Curr Cardiol Rep 17:1. 2015
    ..Public reporting of quality metrics and "pay-for-performance" are some novel performance improvement tools. The impact of these approaches on patient outcomes will be pivotal in improving cardiovascular outcomes in the future...
  4. doi request reprint Risk of major bleeding in different indications for new oral anticoagulants: insights from a meta-analysis of approved dosages from 50 randomized trials
    Partha Sardar
    Texas Tech University Health Sciences Center, El Paso, TX, United States Electronic address
    Int J Cardiol 179:279-87. 2015
    ..A meta-analysis was performed to evaluate the risk of major bleeding with the use of New Oral Anticoagulants (NOACs)...
  5. doi request reprint Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials
    Partha Sardar
    Department of Medicine, New York Medical College Metropolitan Hospital Center, 1901 First Avenue, New York, NY, USA
    J Thromb Thrombolysis 38:1-10. 2014
    ..Use of cangrelor during PCI might reduce the risk of ischemia-driven revascularization and stent thrombosis, without causing extra major bleeding...
  6. doi request reprint Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation
    Partha Sardar
    Department of Medicine, New York Medical College, New York, New York Electronic address
    Am J Cardiol 113:1173-7. 2014
    ..60, 95% CI 0.41 to 0.87). In conclusion, periprocedural use of dabigatran for AF ablation was related to a higher risk of thromboembolic complications including stroke and transient ischemic attack...
  7. doi request reprint Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials
    Partha Sardar
    Department of Medicine, New York Medical College Metropolitan Hospital Center, 1901 First Avenue, New York, NY, USA
    Drugs 73:1171-82. 2013
    ..Currently available anticoagulants have limitations for long term treatment of venous thromboembolism (VTE)...
  8. doi request reprint Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis
    Saurav Chatterjee
    Division of Cardiology, St Luke s Roosevelt Hospital Center of the Mount Sinai Health System, New York, New York
    JAMA 311:2414-21. 2014
    ..To date, no analysis has had adequate statistical power to determine whether thrombolytic therapy is associated with improved survival, compared with conventional anticoagulation...
  9. doi request reprint New oral anticoagulants in elderly adults: evidence from a meta-analysis of randomized trials
    Partha Sardar
    Department of Medicine, New York Medical College Metropolitan Hospital Center, New York, New York
    J Am Geriatr Soc 62:857-64. 2014
    ..To evaluate the efficacy and safety of new oral anticoagulants (NOACs) in elderly adults...
  10. doi request reprint New oral anticoagulants in patients with cancer: current state of evidence
    Partha Sardar
    1Department of Medicine, New York Medical College, New York, NY 2Department of Cardiology, St Luke s Roosevelt Hospital of the Mount Sinai Health System, New York, NY 3Department of Medicine, New York Medical College Metropolitan Hospital Center, New York, NY and 4Department of Medicine, Cardiology Division, New York Medical College, Valhalla, NY
    Am J Ther 22:460-8. 2015
    ..Randomized trials of new anticoagulants specific to the cancer population are necessary, and NOAC also need to be evaluated against low-molecular-weight heparin. ..
  11. pmc New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons
    Partha Sardar
    Department of Medicine, New York Medical College, Metropolitan Hospital Center, New York, New York, United States of America
    PLoS ONE 8:e77694. 2013
    ..A systematic review and meta-analysis was performed to compare the efficacy and safety of New Oral Anticoagulants (NOACs) to warfarin in patients with AF and previous stroke or transient ischemic attack (TIA)...
  12. doi request reprint Statins and cognitive function: an updated review
    Saurav Chatterjee
    Division of Cardiovascular Diseases, St Luke s Roosevelt Hospital Center of the Mount Sinai Health System, 1111 Amsterdam Avenue Clark Building, 3rd Floor, New York, NY, 10025, USA
    Curr Cardiol Rep 17:4. 2015
    ..As more randomized control trials are required to definitively settle this, cardiovascular benefits of statins must be weighed against the risks of cognitive decline on an individual basis. ..
  13. doi request reprint Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis
    Parijat Sen
    Department of Medicine, St Michael s Medical Center, Newark, NJ, USA
    Am J Cardiovasc Drugs 16:33-41. 2016
    ..A meta-analysis was performed to evaluate the efficacy and safety of NOACs in patients with AF undergoing cardioversion...
  14. doi request reprint Does Surgical Repair of Moderate Ischemic Mitral Regurgitation Improve Survival? A Systematic Review
    Saurav Chatterjee
    Cardiovascular Diseases, Division of Cardiology, Mount Sinai St Luke s Roosevelt Hospitals, 1111 Amsterdam Avenue, Clark building 3rd floor, New York, NY, 10025, USA
    Curr Cardiol Rep 18:22. 2016
    ..Prospective randomized studies are required to establish clear benefit of performing MVR simultaneously with CABG. ..
  15. doi request reprint Comparable benefit of β-blocker therapy in heart failure across regions of the world: meta-analysis of randomized clinical trials
    Saurav Chatterjee
    Department of Cardiovascular Diseases, St Luke s Roosevelt Hospital of the Mount Sinai Health System, New York, New York, USA
    Can J Cardiol 30:898-903. 2014
    ..This study sought to compare benefits of BB use within randomized controlled trials (RCTs) that enrolled patients with HFrEF from North America (NA) compared with other regions of the world (ROW)...
  16. doi request reprint Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis
    Saurav Chatterjee
    Maimonides Medical Center, Brooklyn, New York, NY 11220, USA
    Pacing Clin Electrophysiol 36:1017-23. 2013
    ....
  17. doi request reprint Meta-analysis of left ventricular hypertrophy and sustained arrhythmias
    Saurav Chatterjee
    Division of Cardiology, Department of Internal Medicine, Mount Sinai St Luke s Roosevelt Hospital, New York, New York Electronic address
    Am J Cardiol 114:1049-52. 2014
    ..Presence of LVH in hypertensive patients is associated with a greater risk of sustained supraventricular/atrial and ventricular arrhythmias, and there is an unmet need for identifying and refining risk stratification for this group...
  18. doi request reprint Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: an updated review of literature
    Saurav Chatterjee
    Division of Cardiovascular Diseases, St Luke s Roosevelt Hospital Center, Division of Cardiology, 1111 Amsterdam Avenue, Clark Building, 3rd Floor, New York, NY, 10025, USA
    Curr Cardiol Rep 16:473. 2014
    ..We present an updated review focusing on the quality-of-life outcomes and issues with this new and important procedural approach. ..
  19. ncbi request reprint Steroids for the prevention of restenosis in bare-metal stents--a systematic review and meta-analysis
    Partha Sardar
    Lenox Hill Cardiovascular Institute, New York, New York, USA
    J Invasive Cardiol 24:98-103. 2012
    ..We reviewed the validity of empirical evidence that periprocedural treatment with steroids at the time of insertion of a BMS may delay restenosis and provide benefit through reductions in adverse clinical events...